Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma

Chun-Ting Ho, Elise Chia-Hui Tan, Pei-Chang Lee, Chi-Jen Chu, Yi-Hsiang Huang, Teh-Ia Huo, Yu-Hui Su, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su

Clin Mol Hepatol. 2024;30(3):406-420. Published online April 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0103

View: 1139 Download: 104

Snapshot

Immunopathogenesis of liver fibrosis in steatotic liver disease

Chaerin Woo, Won-Il Jeong

Clin Mol Hepatol. 2024;30(2):299-302. Published online February 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0113

View: 2063 Download: 83

Original Article

Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis

Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Hong-Lei Ma, Ming-Hua Zheng, Jian Wu, Chunming Ding

Clin Mol Hepatol. 2021;27(2):329-345. Published online January 20, 2021

DOI: https://doi.org/10.3350/cmh.2020.0261

View: 7193 Download: 226 Web of Science: 14 Crossref: 16

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

The lymphatic system in alcohol-associated liver disease

Reiichiro Kondo, Yasuko Iwakiri

Clin Mol Hepatol. 2020;26(4):633-638. Published online September 21, 2020

DOI: https://doi.org/10.3350/cmh.2020.0179

View: 8277 Download: 151 Web of Science: 3 Crossref: 3

Original Article

Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals

Alessio Strazzulla, Giuseppe Coppolino, Giorgio Settimo Barreca, Innocenza Gentile, Laura Rivoli, Maria Concetta Postorino, Maria Mazzitelli, Giuseppe Greco, Chiara Costa, Vincenzo Pisani, Nadia Marascio, Mariadelina Simeoni, Alfredo Focà, Giorgio Fuiano, Daniela Foti, Elio Gulletta, Carlo Torti

Clin Mol Hepatol. 2018;24(2):151-162. Published online April 24, 2018

DOI: https://doi.org/10.3350/cmh.2017.0059

View: 6778 Download: 119 Web of Science: 14 Crossref: 13

Review

Acute-on-chronic liver failure: a new syndrome in cirrhosis

Richard Moreau

Clin Mol Hepatol. 2016;22(1):1-6. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.1

View: 14691 Download: 343 Web of Science: 28 Crossref: 29

6

Hepatic tuberculosis presenting as a Large Liver mass

Yong Moon Shin, M.D.

Clin Mol Hepatol. 2010;16(2):197-200. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.197

View: 4190 Download: 25 Crossref: 1

1

Transient elastography, true or false?

Yeon Seok Seo

Clin Mol Hepatol. 2009;15(4):431-437. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.431

View: 3963 Download: 26 Crossref: 2

3

Changes in liver stiffness during the course of acute hepatitis A

Yeon Seok Seo, M.D., Soon Ho Um, M.D., Sang-jun Suh, M.D., Eun Suk Jung, M.D., Jin Su Jang, M.D., Yong Dae Kwon, M.D., Sang Hoon Park, M.D., Bora Keum, M.D., Yong Sik Kim, M.D., Yoon Tae Jeen, M.D., Hoon Jai Chun, M.D., Chang Duck Kim, M.D., Ho Sang Ryu, M.D.

Clin Mol Hepatol. 2008;14(4):465-473. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.465

View: 4840 Download: 27 Crossref: 10

7

The Korean Journal of Normal range of serum ALT level in patients with chronic hepatitis

Yeon Seok Seo

Clin Mol Hepatol. 2008;14(1):116-121. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.116

View: 4260 Download: 18

2

Cerulein Pancreatitis: Oxidative Stress, Inflammation, and Apoptosis

Hye Young Kim

Clin Mol Hepatol. 2008;12(2):74-80.

View: 1959 Download: 12

Correspondence

Correspondence on Editorial regarding “Dynamic Assessment of Modified Quick Sequential Organ Failure Assessment in Acutely Deteriorated Patients with Chronic Liver Disease”

Do Seon Song, Dong Joon Kim

Received June 12, 2024 Accepted June 14, 2024

DOI: https://doi.org/10.3350/cmh.2024.0448 [Accepted]

View: 421 Download: 5

1 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5413	MAFLD: How is it different from NAFLD?
Viewed By 5222	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5101	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4732	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search